Angiotensin II and Renal Fibrosis
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
— Angiotensin (Ang) II, the main peptide of the renin angiotensin system (RAS), is a renal growth factor, inducing hyperplasia/hypertrophy depending on the cell type. This vasoactive peptide activates mesangial and tubular cells and interstitial fibroblasts, increasing the expression and synthesis of extracellular matrix proteins. Some of these effects seem to be mediated by the release of other growth factors, such as TGF-β. In experimental models of kidney damage, renal RAS activation, cell proliferation, and upregulation of growth factors and matrix production were described. In some of these models, blockade of Ang II actions by ACE inhibitors and angiotensin type 1 (AT 1 ) antagonists prevents proteinuria, gene expression upregulation, and fibrosis, as well as inflammatory cell infiltration. Interestingly, Ang II could also be involved in the fibrotic process because of its behavior as a proinflammatory cytokine, participating in various steps of the inflammatory response: Ang II (1) activates mononuclear cells and (2) increases proinflammatory mediators (cytokines, chemokines, adhesion molecules, nuclear factor κB). Finally, Ang II also regulates matrix degradation. These data show that drugs controlling this complex vasoactive peptide are probably one of the best ways of avoiding fibrosis in progressive renal diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Desmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243
The Progression of Renal Disease
Epstein, F. H., Klahr, S., Schreiner, G., & Ichikawa, I. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806233182505 · Cited by 828
Understanding the nature of renal disease progression
Remuzzi, G., Ruggenenti, P., & Benigni, A. (1997) · Kidney International · doi:10.1038/ki.1997.2 · Cited by 649
Renal injury from angiotensin II-mediated hypertension.
Johnson, R. J., Alpers, C. E., Yoshimura, A., Lombardi, D., Pritzl, P., Floege, J., & Schwartz, S. M. (1992) · Hypertension · doi:10.1161/01.hyp.19.5.464 · Cited by 536
Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases
Matsubara, H. (1998) · Circulation Research · doi:10.1161/01.res.83.12.1182 · Cited by 478
Interactions of Transforming Growth Factor-β and Angiotensin II in Renal Fibrosis
Border, W. A., & Noble, N. A. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.181 · Cited by 447
Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists
Taal, M. W., & Brenner, B. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00031.x · Cited by 439
Proinflammatory actions of angiotensins
Ruiz-Ortega, M., Lorenzo, O., Suzuki, Y., Rupérez, M., & Egido, J. (2001) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200105000-00005 · Cited by 412
Self-citationRuiz-Ortega, M., Lorenzo, O., Rupérez, M., König, S., Wittig, B., & Egido, J. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1266 · Cited by 331
Self-citationIshidoya, S., Morrissey, J., McCracken, R., Reyes, A., & Klahr, S. (1995) · Kidney International · doi:10.1038/ki.1995.183 · Cited by 319
Angiotensin II as a renal growth factor.
Wolf, G., & Neilson, E. G. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v391531 · Cited by 307
Ruiz‐Ortega, M., Bustos, C., Hernández-Presa, M. Á., Lorenzo, Ó., Plaza, J. J. G., & Egido, J. (1998) · PubMed · Cited by 284
Self-citationGupta, S., Clarkson, M. R., Duggan, J., & Brady, H. R. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00301.x · Cited by 283
Wolf, G., Ziyadeh, F. N., Thaiss, F., Tomaszewski, J., Caron, R. J., Wenzel, U., Zahner, G., Helmchen, U., & Stahl, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119615 · Cited by 253
Ruiz-Ortega, M., Bustos, C., Hernández-Presa, M. A., Lorenzo, O., Plaza, J. J., & Egido, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.430 · Cited by 230
Self-citationTang, W. W., Ulich, T., Lacey, D., Hill, D., Qi, M., Kaufman, S. A., Van, G. Y., Tarpley, J. E., & Yee, J. (1996) · Europe PMC (PubMed Central) · Cited by 226
Viedt, C., Soto, U., Krieger-Brauer, H. I., Fei, J., Elsing, C., Kübler, W., & Kreuzer, J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.4.940 · Cited by 216
Ruiz-Ortega, M., & Egido, J. (1997) · Kidney International · doi:10.1038/ki.1997.480 · Cited by 209
Self-citationWu, L. L., Cox, A., Roe, C. J., Dziadek, M., Cooper, M. E., & Gilbert, R. E. (1997) · Kidney International · doi:10.1038/ki.1997.214 · Cited by 209
Vasoactive hormones and renal sclerosis
Egido, J. (1996) · Kidney International · doi:10.1038/ki.1996.82 · Cited by 198
Self-citationPlasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo
Nakamura, S., Nakamura, I., Ma, L., Vaughan, D. E., & Fogo, A. B. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00160.x · Cited by 178
Ruiz-Ortega, M., Lorenzo, Ó., Rupérez, M., Blanco, J., & Egido, J. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64130-2 · Cited by 176
Self-citationAngiotensin II Activates Collagen I Gene Through a Mechanism Involving the MAP/ER Kinase Pathway
Tharaux, P.-L., Chatziantoniou, C., Fakhouri, F., & Dussaule, J.-C. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.330 · Cited by 173
Alpers, C. E., Hudkins, K. L., Floege, J., & Johnson, R. J. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v52201 · Cited by 166
Mezzano, S. A., Droguett, A., Burgos, M. E., Ardiles, L. G., Aros, C., Caorsi, I., & Egido, J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00830.x · Cited by 147
Self-citationRuiz‐Ortega, M., González, S., Serón, D., Condom, E., Bustos, C., Largo, R., González, E., Ortíz, A., & Egido, J. (1995) · Kidney International · doi:10.1038/ki.1995.476 · Cited by 122
Self-citationMacrophages in acute glomerular inflammation
Cattell, V. (1994) · Kidney International · doi:10.1038/ki.1994.128 · Cited by 121
Ruiz‐Ortega, M., Lorenzo, Ó., & Egido, J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00089.x · Cited by 117
Self-citationAngiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney.
Lapinski, R., Perico, N., Remuzzi, A., Sangalli, F., Benigni, A., & Remuzzi, G. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v75653 · Cited by 110
Schneider, A., Panzer, U., Zahner, G., Wenzel, U. O., Wolf, G., Thaiss, F., Helmchen, U. M., & Stahl, R. A. K. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00543.x · Cited by 99
In Vivo Study of AT1and AT2Angiotensin Receptors in Apoptosis in Rat Blood Vessels
Diep, Q. N., Li, J., & Schiffrin, E. L. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.617 · Cited by 95
Ruiz‐Ortega, M., Lorenzo, Ó., Rupérez, M., Suzuki, Y., & Egido, J. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_1.27 · Cited by 87
Self-citationLife-Death Balance Within the Cell
Barinaga, M. (1996) · Science · doi:10.1126/science.274.5288.724 · Cited by 66
Cited by
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
“ANG II also plays an important role in the development of renal and hepatic fibrosis [142].”
BackgroundFibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Inflammation and angiotensin II
Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., & Egido, J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00271-6 · Cited by 694
Self-citationKhan, A., Benthin, C., Zeno, B., Albertson, T. E., Boyd, J., Christie, J. D., Hall, R., Poirier, G., Ronco, J. J., Tidswell, M., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1823-x · Cited by 602
Bataller, R., Schwabe, R. F., Choi, Y. H., Yang, L., Paik, Y. H., Lindquist, J., Qian, T., Schoonhoven, R., Hagedorn, C. H., Lemasters, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18212 · Cited by 548
Metadata
- Authors
- Mezzano, S. A., Ruiz-Ortega, M., & Egido, J.
- Venue
- Hypertension
- Published
- 2001-09
- Volume
- 38
- Issue
- 3
- Pages
- 635-638
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2124579702
- Cited by
- 523
- References
- 33
- FWCI
- 14.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.